InvestorsHub Logo
Followers 20
Posts 5331
Boards Moderated 0
Alias Born 01/04/2012

Re: Just the facts maam post# 13873

Wednesday, 06/15/2022 4:44:14 AM

Wednesday, June 15, 2022 4:44:14 AM

Post# of 14871
Correction: The time between AbbVie submitting a Certification request for the "Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Adults With Moderate to Severe Endometriosis-Associated Pain" to announcing the PDUFA target date was 10 months and 8 days not 9 months and 8 days. AbbVie did announce that they submitted an NDA to the FDA 3 months and 4 days after Trial Certification submission and announced receiving a priority review 1 month and 21 days later.

Hopefully Libi keeps similar timelines. If so, it pushes approval towards mid January. Expected launch date for Amgen's Humira biosimilar, Amjevita, is Jan. 31, 2023
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News